Business Description
Beijing Leadman Biochemistry Co Ltd
NAICS : 325413
SIC : 2835
ISIN : CNE100001C22
Share Class Description:
SZSE:300289: Class ACompare
Compare
Traded in other countries / regions
300289.China IPO Date
2012-02-16Description
Beijing Leadman Biochemistry Co Ltd is a biotechnology company based in China. The company is focusing on research and development, manufacture, and sales of in vitro diagnostic (IVD) products. The company has core competencies in biochemistry, in vitro diagnostic reagents and instruments. Its product offering includes biochemical raw materials such as enzymes, coenzymes, antibodies, buffers, and enzyme substrates; biochemistry diagnostic and companion reagents; and medical test instruments.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 138.27 | |||||
| Equity-to-Asset | 0.92 | |||||
| Debt-to-EBITDA | -1.12 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 18.39 | |||||
| Beneish M-Score | -3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -6.6 | |||||
| 3-Year EBITDA Growth Rate | 22.5 | |||||
| 3-Year FCF Growth Rate | -4.6 | |||||
| 3-Year Book Growth Rate | 2.3 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.08 | |||||
| 9-Day RSI | 58.99 | |||||
| 14-Day RSI | 59.04 | |||||
| 6-1 Month Momentum % | 13.1 | |||||
| 12-1 Month Momentum % | -19.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 14.83 | |||||
| Quick Ratio | 13.53 | |||||
| Cash Ratio | 10.55 | |||||
| Days Inventory | 186.91 | |||||
| Days Sales Outstanding | 117.37 | |||||
| Days Payable | 38.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.18 | |||||
| Dividend Payout Ratio | 0.31 | |||||
| Forward Dividend Yield % | 0.18 | |||||
| 5-Year Yield-on-Cost % | 0.18 | |||||
| 3-Year Average Share Buyback Ratio | -8.9 | |||||
| Shareholder Yield % | 0.81 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.97 | |||||
| Operating Margin % | -0.15 | |||||
| Net Margin % | -1.83 | |||||
| FCF Margin % | 9.3 | |||||
| ROE % | -0.42 | |||||
| ROA % | -0.38 | |||||
| ROIC % | -0.03 | |||||
| ROC (Joel Greenblatt) % | -0.85 | |||||
| ROCE % | -0.28 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 172.5 | |||||
| Shiller PE Ratio | 55.2 | |||||
| PS Ratio | 6.74 | |||||
| PB Ratio | 1.73 | |||||
| Price-to-Tangible-Book | 1.92 | |||||
| Price-to-Free-Cash-Flow | 71.68 | |||||
| Price-to-Operating-Cash-Flow | 43.82 | |||||
| EV-to-EBIT | -441.95 | |||||
| EV-to-EBITDA | -441.95 | |||||
| EV-to-Revenue | 5.56 | |||||
| EV-to-FCF | 52.96 | |||||
| Price-to-Projected-FCF | 1.27 | |||||
| Price-to-Median-PS-Value | 1.19 | |||||
| Price-to-Graham-Number | 3.83 | |||||
| Price-to-Net-Current-Asset-Value | 3.17 | |||||
| Price-to-Net-Cash | 4.76 | |||||
| Earnings Yield (Greenblatt) % | -0.23 | |||||
| FCF Yield % | 1.25 | |||||
| Forward Rate of Return (Yacktman) % | -36.23 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Leadman Biochemistry Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 403.235 | ||
| EPS (TTM) (Â¥) | -0.012 | ||
| Beta | 1.04 | ||
| Volatility % | 42.25 | ||
| 14-Day RSI | 59.04 | ||
| 14-Day ATR (Â¥) | 0.244781 | ||
| 20-Day SMA (Â¥) | 5.3055 | ||
| 12-1 Month Momentum % | -19.57 | ||
| 52-Week Range (Â¥) | 3.45 - 6.55 | ||
| Shares Outstanding (Mil) | 544.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Leadman Biochemistry Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Leadman Biochemistry Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Beijing Leadman Biochemistry Co Ltd Frequently Asked Questions
What is Beijing Leadman Biochemistry Co Ltd(SZSE:300289)'s stock price today?
The current price of SZSE:300289 is ¥5.52. The 52 week high of SZSE:300289 is ¥6.55 and 52 week low is ¥3.45.
When is next earnings date of Beijing Leadman Biochemistry Co Ltd(SZSE:300289)?
The next earnings date of Beijing Leadman Biochemistry Co Ltd(SZSE:300289) is .
Does Beijing Leadman Biochemistry Co Ltd(SZSE:300289) pay dividends? If so, how much?
The Dividend Yield %  of Beijing Leadman Biochemistry Co Ltd(SZSE:300289) is 0.18% (As of Today), Highest Dividend Payout Ratio of Beijing Leadman Biochemistry Co Ltd(SZSE:300289) was 0.43. The lowest was 0.06. And the median was 0.17. The  Forward Dividend Yield % of Beijing Leadman Biochemistry Co Ltd(SZSE:300289) is 0.18%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers